The Age of Personalized Medicine: Trends and Opportunities Reflected in the U.S. Experience
17 April 2013
Foley and ChinaBio invite you to join us for our upcoming executive workshop, which will explore this paradigm shift toward personalized medicine and its global implications for China’s life sciences business executives, health care professionals, and academic researchers.
Topics to be discussed include:
- Business and social factors driving the move to personalized medicine, including non-sustainable medical costs, a decline in pharma R&D productivity, and the rise of patient-oriented health care
- Regulatory and intellectual property challenges to formulating a viable business model in the personalized medicine arena
- Potential for strategic collaborations with U.S. companies focused on different aspects of personalized medicine, such as genomic sequencing, biomarker substantiation, genetic testing, and electronic health records
- Post-grant patent issues, reducing patent litigation cost, and other risk management issues in the United States
Confirmed Speakers
- Andrew S. Baluch, Special Counsel, Intellectual Property Department and China Practice, Foley & Lardner LLP
- Nathan A. Beaver, Partner, Life Sciences Industry Team, Foley & Lardner LLP
- Song (Max) Lin, China Associate, Chemical, Biotechnology & Pharmaceutical Practice, Foley & Lardner LLP
- Alex Y. Nie, Associate, Chemical, Biotechnology & Pharmaceutical Practice and Life Sciences Industry Team, Foley & Lardner LLP
- Greg B. Scott, President and Founder, ChinaBio LLC
This workshop is complimentary; however, due to seating limitations, pre-registration is required. An acknowledgement email will be sent upon receipt of your registration request.
For more information, contact Delia Dai at [email protected] or 001.312.832.4506, or Emily Zhang at [email protected] or 86.21.5137.0751, ext. 20.
People
Related Insights
14 January 2025
Events
Crypto Under a New Political Environment
Patrick Daugherty (Partner, Chicago) will be joining the Securities Traders Association of Chicago (STAC) as a panelist at their 99th Annual Mid-Winter Meeting.
14 January 2025
Health Care Law Today
Massachusetts: New Year, New Law — Governor Signs “An Act enhancing the market review process” (House Bill No. 5159)
On January 8, 2025, Governor Maura Healey signed into law H.B. 5159, “an Act enhancing the market review process.”
13 January 2025
Labor & Employment Law Perspectives
Illinois Human Rights Act Now Protects Employees With “Family Responsibilities”
As of January 1, 2025, Illinois became the latest in a minority of states and municipalities to expand employment protections for employees who act as family caregivers.